FDA Drug recall D-310-2013
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg
- FDA Drug
- Class III
- terminated
- Published 2013-05-08
On 2013-05-08 the FDA classified a Class III recall of Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg by Reckitt Benckiser, citing subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-310-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-03-18 |
| Published | 2013-05-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Reckitt Benckiser |
| Distribution | US |
Product
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
Reason
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Identifiers
| code_info | 16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141…16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13, |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-310-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.